100
Participants
Start Date
May 26, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
ACTIVE_NOT_RECRUITING
General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 244339, Athens
ACTIVE_NOT_RECRUITING
General Anti-cancer Hospital Agios Savvas /ID# 244408, Athens
ACTIVE_NOT_RECRUITING
General Hospital of Athens Gennimatas /ID# 245968, Athens
ACTIVE_NOT_RECRUITING
General Hospital of Athens Laiko /ID# 244338, Athens
ACTIVE_NOT_RECRUITING
General Hospital of Athens Laiko - Hematology Location /ID# 244234, Athens
ACTIVE_NOT_RECRUITING
University General Hospital Attikon /ID# 248265, Athens
ACTIVE_NOT_RECRUITING
Olympion General Clinic /ID# 268392, Pátrai
COMPLETED
University General Hospital of Patras /ID# 244335, RION Patras Achaia
ACTIVE_NOT_RECRUITING
University General Hospital of Ioannina /ID# 244336, Ioannina
RECRUITING
Papageorgiou General Hospital /ID# 248266, Thessaloniki
ACTIVE_NOT_RECRUITING
General Hospital of Thessaloniki George Papanikolaou /ID# 244237, Thessaloniki
ACTIVE_NOT_RECRUITING
General University Hospital of Alexandroupolis /ID# 244235, Alexandroupoli
COMPLETED
University General Hospital of Heraklion PA.G.N.I /ID# 244337, Heraklion
Lead Sponsor
AbbVie
INDUSTRY